Nls pharmaceutics and kadimastem unveil multi-target approach to diabetes, expanding beyond glp-1 therapies

Revolutionizing diabetes treatment: introduction of cutting-edge, multi-targeted innovation to transform diabetes care. diabetes more than just a metabolic disorder: diabetes is a multi-systemic disease impacting the central nervous system (cns), immune function, and cellular metabolism.
NLSP Ratings Summary
NLSP Quant Ranking